β-Carotene inhibits NF-κB and restrains diethylnitrosamine-induced hepatic inflammation in Wistar rats

beta-Carotene exhibits antioxidant and hepatoprotective activities via a multitude of biochemical mechanisms. However, the action mechanism involved in antioxidant and anti-inflammatory effects of this carotene in chronic liver diseases is not fully understood. In the present investigation, we have attempted to outline a plausible mechanism of beta-carotene action against liver fibrosis in albino Wistar rats. To induce hepatic fibrosis, diethylnitrosamine (DEN) was administered in experimental rats for two weeks. DEN treated rats were divided into four groups, wherein each group comprised of five rats. beta-Carotene supplement attenuated DEN-induced elevation in LFT markers (P < 0.05); averted depletion of glycogen (24%, P < 0.05) and, increased nitrite (P < 0.05), hydroxyproline (similar to 67%, P < 0.05) and collagen levels (similar to 65%, P < 0.05). Confocal microscopy of tissue sections stained with picrosirius red revealed accrued collagen in DEN-administered group, which was found to be reduced by beta-carotene supplementation. Furthermore, beta-carotene decreased the expression of iNOS/NOS-2 and NF-kappa B, as revealed by immunohistochemistry and Western immunoblotting. Collectively, these results demonstrate that beta-carotene mitigates experimental liver fibrosis via inhibition of iNOS and NF-kappa B in-vivo. Thus, beta-carotene may be suggested as a possible nutraceutical to curb experimental liver fibrosis.